Compass Therapeutics, Inc.

Q3 2023 13F Holders

Symbol
CMPX
CUSIP
20454B104
Type
Equity
Class
COM
Num filings
78
Total reported value, excl. options
$177 M
Manager Report Date Value ($000) Shares Option Type